ARK Genomic Revolution ETF
ARKG
2 hedge funds and large institutions have $854K invested in ARK Genomic Revolution ETF in 2014 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
19.62% more ownership
Funds ownership: 0% → 19.62% (+20%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$770K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $801K | +$770K | +37,723 | New |
|
2
UBS Group
Zurich,
Switzerland
| $53K | +$51K | +2,500 | New |
|
ARKG Hedge Fund Activity: Q4 2014 in Review
2 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q4 2014, worth a combined $854K.
Buyers outnumbered sellers: 2 funds opened new ARKG positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $770K.
- 2 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q4 2014, up from 0 in Q3 2014.
- Funds reported $854K of ARK Genomic Revolution ETF stock for Q4 2014.
- 2 funds opened new ARK Genomic Revolution ETF positions in Q4 2014 and 0 closed out, a net change of +2 holders.
- The largest ARK Genomic Revolution ETF buyer in Q4 2014 was Jane Street, an estimated $770K added.
Based on aggregated 13F filings for Q4 2014.